Management of hepatitis C after transplantation: A long way from success

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 11, 2004, Pages 1131-1133

  Dove, Lorna M ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Hepatitis C; Interferon; Liver transplantation

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

CLINICAL TRIAL; DISEASE COURSE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TRANSPLANTATION; TREATMENT OUTCOME;

GENOTYPE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 8444238597     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200411000-00008     Document Type: Review

References (21)

1. Yoo H, Maheshwri A, Thuluvath P. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transplantation 2003; 9:897-904.
2. Berenguer M, Prieto M, Rayon M, Mora J, Pastor M, Ortiz V et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32(4 pt 1):852-858.
3. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. Association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122:889-896.
4. Berenguer M, Crippin J, Gish R, et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003; 38:34-41.
5. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32:1125-1130.
6. Neuberger J. Treatment of hepatitis C virus infection in the allograft. Liver Transplantation 2003; 9:S101-S108.
7. Thomas R, Brems J, Guzman-Hartman G, Yong S, Cavaliere P, Van Thiel D. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transplantation 2003; 9:905-915.
8. Crippin J, McCashland T, Terrault N, Sheiner P, Charlton M. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transplantation 2002; 8:350-355.
9. Reddy K, Weppler D, Zervos X. Recurrent HCV infection following OLTx: the role of early post OLTx interferon treatment. Hepatology 1996; 24:295A.
10. Singh N, Gayowski T, Wannstedt C. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients. Transplantation 1998; 65:82-86.
11. Sheiner P, Boros P, Klion G. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28:831-838.
12. Mazzaferro V, Regalia E, Pulvirenti A. Prophylaxis against HCV recurrence after liver transplantation. Effect of interferon and ribavirin combination. Transplant Proceedings 1997; 29:519-521.
13. Fisher L, Sterneck M, Valentin-Gamazo C, Feucht J, Malago M, Broelsch C. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. Transplantation Proceedings 1999; 31:494-495.
14. Gotz G, Schon M, Haefker A. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin. Transplant Proceedings 1998; 30:2104-2106.
15. Bizollon T, Ducerf C, Baulieux J, Trepo C. Treatment of recurrent hepatitis C following liver transplantation. Current Gastroenterology Reports 1999; 1:15-19.
16. Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, et al. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 2003; 52:283-287.
17. Lamm N, Neumann A, Gretch D, Wiley T, Perelson A, Layden T. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology 1997; 26:226.
18. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982.
19. Cotler S, Ganger D, Kaur S, Rosenblate H, Jakate S, Sullivan DG, et al. Daily interferon therapy for hepatitis C virus infection in liver transplant recipients. Transplantation 2001; 71:261-266.
20. Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon [alpha] 2b and ribavirin: an open-label series. Transplantation 2004; 77:190-194.
21. McHutchinson J, Gordon S, Schiff E. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339:1485-1492.